Skip to search formSkip to main contentSkip to account menu

RARRES3 wt Allele

Known as: RIG1, Retinoic Acid Receptor Responder (Tazarotene Induced) 3 wt Allele, TIG3 
Human RARRES3 wild-type allele is located in the vicinity of 11q23 and is approximately 9 kb in length. This allele, which encodes retinoic acid… 
National Institutes of Health

Related topics

Related topics

4 relations
Cell Differentiation processCell Proliferation Regulatory Processchromosome 11q23

Broader (1)

RARRES3 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
High expression of TIG3 predicts poor survival in patients with primary glioblastoma
TIG3 (tazarotene-induced gene 3) has been reported to suppress the progression of several malignancies, where this gene is… 
2014
2014
Eosinophilic Pustular Folliculitis: Association with Long-Term Immunosuppressant Use in a Solid Organ Transplant Recipient
Dear Editor: Eosinophilic pustular folliculitis (EPF) is an inflammatory disease that is characterized by pruriticfollicular… 
2012
2012
TIG3 interaction at the centrosome alters microtubule distribution and centrosome function
TIG3 is an important pro-differentiation regulator that is expressed in the suprabasal epidermis. We have shown that TIG3… 
2009
2009
PRMT 5 , a Novel TRAIL Receptor-Binding Protein , Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κ B Activation
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily and has selective… 
Review
2009
Review
2009
The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulated by E 2 F 1
The Hypermethylated in Cancer 1 (HIC1) gene encodes a zinc finger transcriptional repressor that cooperates with p53 to suppress… 
2007
2007
Optimal Management of the T 1 G 3 Bladder Cancer
Management decisions for a patient with a highgrade T1 urothelial cancer of the bladder are both critical and controversial. In… 
2005
2005
Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
AIM Conservative therapy using deep transurethral resection (TUR) followed by radiochemotherapy is a novel treatment strategy in… 
2005
2005
[Predictive value of progression of muscularis mucosae and percentage G3 cells in vesical TIG3 tumours].
INTRODUCTION AND OBJECTIVE Vesical tumor T1G3 constitutes the border between the superficial tumor and the infiltrante tumor… 
2003
2003
Comparison of a standard BCG dose (81 MG) versus a three-fold reduced dose (27 MG) in high risk superficial bladder cancer (TIG3, TIS), A cueto prospective randomised study #95012
2002
2002
Intravesical bacillus calmette-guerin treatment improves patient survival in conservatively treated TIG3 bladder tumours
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)